Role of secukinumab in ankylosing spondylitis with tubercular uveitis.
Indian J Ophthalmol
; 68(11): 2569-2572, 2020 Nov.
Article
em En
| MEDLINE
| ID: mdl-33120695
ABSTRACT
We present the case of a 32-year-old Indian male one-eyed individual with a history of unilateral panuveitis with HLA B 27 positive spondyloarthropathy on systemic immunosuppressant (Adalimumab). He developed recurrent inflammation in the same eye in a span of 2 years, later complicated with retinal vasculitis. On evaluation, he was diagnosed with tubercular uveitis and started on antitubercular treatment along with systemic steroids. Inview of Increased IOP due to steroid response, Inj. Secukinumab ( IL 17 A inhibitor) was started and significant improvement was noted.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Espondilite Anquilosante
/
Uveíte
Tipo de estudo:
Diagnostic_studies
Limite:
Adult
/
Humans
/
Male
Idioma:
En
Revista:
Indian J Ophthalmol
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Índia